Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 13/11/2013, Revision: 28, Status: Authorised
Human medicines European public assessment report (EPAR): Kaletra, lopinavir,ritonavir, Date of authorisation: 19/03/2001, Revision: 64, Status: Authorised
Minutes - PDCO minutes of the 25-28 February 2025 meeting
HMPC meeting report on European Union herbal monographs, guidelines and other activities - 17-19 March 2025
Overview of comments received on the draft revision of EMA’s Policy on handling competing interests of scientific committee members and experts
Electronic submission of Article 57(2) data: questions and answers
Chapter 3.II: XEVPRM detailed user guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the EMA
List of industry subject matter experts and list of planned calls for industry subject matter experts
QRD Appendix V - Adverse-drug-reaction reporting details
Human medicines European public assessment report (EPAR): Esbriet, pirfenidone, Date of authorisation: 27/02/2011, Revision: 35, Status: Authorised